Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series

S. Takei; N. Hama; Y. Mizukawa; H. Takahashi; F. Miyagawa; H. Asada; R. Abe

doi:10.1111/jdv.17838

Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series

S. Takei, N. Hama, Y. Mizukawa, H. Takahashi, F. Miyagawa, H. Asada, R. Abe

皮膚科学

研究成果: Letter › 査読

2 被引用数 (Scopus)

本文言語	English
ページ（範囲）	e310-e313
ジャーナル	Journal of the European Academy of Dermatology and Venereology
巻	36
号	4
DOI	https://doi.org/10.1111/jdv.17838
出版ステータス	Published - 2022 4月

ASJC Scopus subject areas

皮膚病学
感染症

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1111/jdv.17838

他のファイルとリンク

引用スタイル

Takei, S., Hama, N., Mizukawa, Y., Takahashi, H., Miyagawa, F., Asada, H., & Abe, R. (2022). Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series. Journal of the European Academy of Dermatology and Venereology, 36(4), e310-e313. https://doi.org/10.1111/jdv.17838

Takei, S, Hama, N, Mizukawa, Y, Takahashi, H, Miyagawa, F, Asada, H & Abe, R 2022, 'Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series', Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 4, pp. e310-e313. https://doi.org/10.1111/jdv.17838

@article{f24cc8ba3cc64fb297f71c105c8da550,

title = "Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series",

author = "S. Takei and N. Hama and Y. Mizukawa and H. Takahashi and F. Miyagawa and H. Asada and R. Abe",

note = "Funding Information: This study was supported by Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (no. H26‐nanchi[nan]‐ippan‐081). ",

year = "2022",

month = apr,

doi = "10.1111/jdv.17838",

language = "English",

volume = "36",

pages = "e310--e313",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

T2 - evidence from a 49-case series

AU - Takei, S.

AU - Hama, N.

AU - Mizukawa, Y.

AU - Takahashi, H.

AU - Miyagawa, F.

AU - Asada, H.

AU - Abe, R.

N1 - Funding Information: This study was supported by Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (no. H26‐nanchi[nan]‐ippan‐081).

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85120486779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120486779&partnerID=8YFLogxK

U2 - 10.1111/jdv.17838

DO - 10.1111/jdv.17838

M3 - Letter

C2 - 34839562

AN - SCOPUS:85120486779

VL - 36

SP - e310-e313

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 4

ER -